In vascular studies where acetylcholine was used, Sugen hypoxia treatment significantly reduced the relaxation response, indicating the involvement of endothelial dysfunction in the development of the disease, which was partially mitigated by MMP9 deletion (Figure 2). This evidence concerns the gene MMP9 and endothelial dysfunction.